Thyroiditis
The low-uptake thyrotoxicosis, distinguishing it from Graves disease
Quick Answer
Thyroiditis causes thyrotoxicosis by releasing preformed hormone from an inflamed, damaged gland — not by overproduction — so radioiodine uptake (RAIU) is low, the mirror image of Graves disease. Recognizing this pattern prevents inappropriate I-131: there is no trapping tissue to treat. Management is supportive (beta-blockade; NSAIDs/steroids for the painful subacute form) through an often triphasic course (thyrotoxic → hypothyroid → recovery). Always exclude a recent iodine load and exogenous thyroid hormone, which also produce low-uptake thyrotoxicosis.
Background & Pathophysiology
Thyroiditis is destructive/inflammatory thyroid injury that spills stored T4/T3 into the circulation. Because the follicular cells are damaged and TSH is suppressed, iodine trapping falls — hence low RAIU. The subtypes:
- Subacute (de Quervain / granulomatous): often painful, post-viral, with elevated ESR/CRP; typically triphasic and self-limited.
- Painless / silent (a variant of autoimmune thyroiditis) and postpartum thyroiditis: painless, antibody-associated, often triphasic.
- Amiodarone-induced thyrotoxicosis type 2 (destructive; low uptake, low vascularity on Doppler) — contrast with type 1 (iodine-induced overproduction in nodular glands).
- Hashimoto (chronic lymphocytic): usually hypothyroid, but can have an early hashitoxicosis phase.
Clinical & Laboratory
Thyrotoxic symptoms (palpitations, tremor, heat intolerance) identical to Graves, but without ophthalmopathy/pretibial myxedema. Labs: suppressed TSH, elevated free T4/T3; elevated ESR/CRP and tender gland in subacute; TPO antibodies in autoimmune forms; a low or normal thyroglobulin is expected in factitious (exogenous) thyrotoxicosis, distinguishing it from true thyroiditis.
Imaging Role
The RAIU / pertechnetate scan sorts the thyrotoxicosis differential:
| Uptake | Cause |
|---|---|
| Low/absent | Thyroiditis, exogenous hormone, iodine load, struma ovarii (ectopic) |
| Diffusely increased | Graves disease |
| Focal increased, suppressed background | Toxic adenoma / toxic multinodular goiter |
Color-flow Doppler complements uptake: low vascularity in destructive thyroiditis (and AIT type 2) vs the "thyroid inferno" hypervascularity of Graves.
Interpretation & Decision
A low RAIU in a thyrotoxic patient means the gland is leaking or loaded, not making — do not give I-131. Confirm there is no recent iodinated contrast/amiodarone/kelp, and consider exogenous hormone (check thyroglobulin — low in factitious). Anticipate the hypothyroid phase; most patients recover, though postpartum/silent forms may leave permanent hypothyroidism.
Differential Diagnosis
Graves disease (high uptake, orbitopathy), toxic nodular disease (focal uptake), exogenous/factitious thyrotoxicosis (low thyroglobulin), iodine-induced (Jod-Basedow), struma ovarii (pelvic uptake, absent neck uptake), and amiodarone type 1 vs type 2.
Reporting Checklist
- State the RAIU value with timing/reference range and the scan pattern (low/absent).
- Note Doppler vascularity if performed (low in destructive forms).
- Explicitly flag that low uptake is not a radioiodine indication; recommend supportive management.
- Document iodine-load/medication history.
Common Pitfalls
- Treating thyroiditis as Graves — wasted, ineffective radioiodine.
- Missing exogenous levothyroxine or iodine load as the cause of low-uptake thyrotoxicosis.
- Overlooking the hypothyroid phase and stopping surveillance early.
- Conflating amiodarone type 1 (iodine-induced, treat the overproduction) with type 2 (destructive, steroids).
Board Pearls
Thyroiditis causes thyrotoxicosis by releasing preformed hormone from an inflamed gland, not by overproduction — so RAIU is low, the mirror image of Graves. That single finding prevents inappropriate I-131 (nothing is trapping iodine to treat). Management is supportive (beta-blockade; NSAIDs/steroids for pain) through an often triphasic self-limited course.
Always exclude a recent iodine load and exogenous hormone, which also suppress uptake — check thyroglobulin (low in factitious/exogenous thyrotoxicosis). Doppler shows low vascularity in destructive thyroiditis vs the "thyroid inferno" of Graves.
Distinguish amiodarone-induced thyrotoxicosis type 2 (destructive, low uptake/low vascularity, steroid-responsive) from type 1 (iodine-induced overproduction in nodular glands). Consider struma ovarii when the neck uptake is absent but the patient is thyrotoxic (ectopic thyroid tissue concentrates iodine in the pelvis).
Related Pages
- Tracer: Radioiodine (I-123/I-131); diseases: Hyperthyroidism, Thyroid nodule.
Figure / Diagram Suggestions
- A low-uptake vs Graves diffuse-uptake teaching pair.
- A triphasic thyroiditis timeline (thyrotoxic → hypothyroid → recovery).
- A Doppler "low-flow destructive" vs "thyroid inferno" comparison.
Self-Check
Q1. Why is radioiodine uptake low in thyroiditis despite thyrotoxicosis?
Answer: The gland is releasing preformed stored hormone from inflammatory damage, not overproducing — trapping is suppressed, so RAIU is low.
Q2. A thyrotoxic patient has low RAIU. What two non-thyroiditis causes must you exclude?
Answer: Exogenous thyroid hormone (check low thyroglobulin) and a recent iodine load (contrast, amiodarone, kelp).
Q3. How does color-flow Doppler help separate destructive thyroiditis from Graves?
Answer: Destructive thyroiditis shows low vascularity; Graves shows hypervascular "thyroid inferno."
Q4. Distinguish amiodarone-induced thyrotoxicosis type 1 from type 2.
Answer: Type 1 = iodine-induced overproduction in nodular glands; Type 2 = destructive thyroiditis (low uptake/low vascularity, steroid-responsive).
Evidence & sources
https://nuc.med/thyroiditis/ Report an issue